下尿路症状的全球负担与时间趋势:系统综述与荟萃分析
该系统综述与荟萃分析纳入36个国家222项人群流行病学研究、共1,692,110例样本,旨在评估下尿路症状(LUTS)的全球患病率。结果显示任何LUTS总体患病率为63.2%(95% CI=58.0-68.1),中重度LUTS为31.3%(95% CI=28.8-33.8),男性、≥60岁人群及亚洲人群负担更高,且患病率自1990年代以来呈上升趋势。
要点
- 任何LUTS总体患病率为63.2%(95% CI=58.0-68.1),中重度LUTS为31.3%(95% CI=28.8-33.8)。
- 中重度LUTS患病率男性为35.2%(95% CI=32.1-38.5),≥60岁人群为39.0%(95% CI=33.4-44.8;I²=99.9%)。
- 中重度LUTS患病率从1990-1999年的27.4%(95% CI=24.5-30.3)升至2010-2019年的36.2%(95% CI=30.7-41.9)。
核心结论
- 本研究为首个全面评估LUTS全球患病率的荟萃分析,发现一般人群中LUTS患病率较高,男性、老年人及亚洲人群负担更高,且自1990年代以来LUTS患病率呈上升趋势。
研究设计与样本
- 系统综述与荟萃分析,检索MEDLINE与Embase自建库至2021年1月1日的人群流行病学研究。
- 纳入标准为:样本量与患病率信息充分、研究对象年龄≥15岁、LUTS诊断标准明确。
- 最终纳入来自36个国家的222项研究,涉及1,692,110例样本和632,933例LUTS患者。
- 采用随机效应模型合并率估计值,置信区间基于精确二项分布和检验评分法。
主要发现
- 任何LUTS总体患病率为63.2%(95% CI=58.0-68.1),中重度LUTS总体患病率为31.3%(95% CI=28.8-33.8)。
- 最常见的症状为储尿期症状,患病率56.7%(95% CI=51.0-62.4),其次为排尿期症状36.4%(95% CI=27.8-45.4)和排尿后症状30.7%(95% CI=19.2-43.6)。
- 中重度LUTS患病率男性为35.2%(95% CI=32.1-38.5),≥60岁人群为39.0%(95% CI=33.4-44.8;I²=99.9%)。
- 中重度LUTS患病率从1990-1999年的27.4%(95% CI=24.5-30.3)升至2000-2009年的31.9%(95% CI=27.3-36.7),2010-2019年进一步升至36.2%(95% CI=30.7-41.9)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 年龄≥60岁人群中重度LUTS患病率合并时异质性I²=99.9%。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Lower urinary tract symptoms (LUTS) are common complaint in urology practice and affecting the quality of life for patients. This article aims to perform a systematic review and meta-analysis on the global prevalence of LUTS overall, and according to different patient characteristics. METHODS: We searched MEDLINE and Embase for population-based epidemiological studies reporting the prevalence of LUTS from inception to 1 Jan 2021. Studies which: (1) have enough information on sample size and prevalence; (2) investigate individuals aged 15 or above; and (3) have clear diagnostic criteria for LUTS. We extracted the following information: year of publication; name of the first author; study period; region of recruitment; race; age range; sex; severity; symptoms; and criteria. We pooled rate estimates with exact binomial and test score-based confidence intervals (CIs) using proportions with a random-effects model. RESULTS: We included 222 studies from 36 countries involving 1,692,110 samples and 632,933 patients with LUTS. The overall prevalence of any and moderate-to-severe LUTS was 63.2% (95% CI = 58.0-68.1) and 31.3% (95% CI = 28.8-33.8), respectively. The most common symptom was storage symptoms (56.7%; 95% CI = 51.0-62.4), followed by voiding symptoms (36.4%; 95% CI = 27.8-45.4) and post-micturition symptoms (30.7%; 95% CI = 19.2-43.6). A higher prevalence of moderate-to-severe LUTS was observed in male subjects (35.2%; 95% CI = 32.1-38.5) and individuals aged ≥60 (39.0%; 95% CI = 33.4-44.8; I2 = 99.9%). Its prevalence increased from 27.4% (95% CI = 24.5-30.3) in 1990-1999, to 31.9% (95% CI = 27.3-36.7) in 2000-2009 and 36.2% (95% CI = 30.7-41.9) in 2010-2019. CONCLUSIONS: This study was the first comprehensive meta-analysis examining the global prevalence of LUTS. We identified a high level of LUTS prevalence in the general population, with a higher burden in male subjects, older individuals, and the Asian population. There has been an increasing trend in the prevalence of LUTS since the 1990s.
引用
- Huang J, Chan CK, Yee S, et al. Global burden and temporal trends of lower urinary tract symptoms: a systematic review and meta-analysis. Prostate Cancer Prostatic Dis. 2022. PMID: 36414786. doi:10.1038/s41391-022-00610-w
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。